EcoDrugPlus

Ensembl ID : ML04734a
Gene Symbol: -
External references: -
75 Possible Orthologues:

Ensembl ID : ML047917a
Gene Symbol: -
External references: -
239 Possible Orthologues:

Ensembl ID : ML04795a
Gene Symbol: -
External references: -
120 Possible Orthologues:

Ensembl ID : ML04796a
Gene Symbol: -
External references: -
120 Possible Orthologues:

Ensembl ID : ML048121a
Gene Symbol: -
External references: -
310 Possible Orthologues:

Ensembl ID : ML04822a
Gene Symbol: -
External references: -
144 Possible Orthologues:

Ensembl ID : ML049611a
Gene Symbol: -
External references: -
30 Possible Orthologues:

Ensembl ID : ML05081a
Gene Symbol: -
External references: -
107 Possible Orthologues:

Ensembl ID : ML05085a
Gene Symbol: -
External references: -
50 Possible Orthologues:

Ensembl ID : ML05087a
Gene Symbol: -
External references: -
512 Possible Orthologues:

Ensembl ID : ML050916a
Gene Symbol: -
External references: -
104 Possible Orthologues:

Ensembl ID : ML050915a
Gene Symbol: -
External references: -
47 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).